Molecular genetics of hereditary sensory neuropathies

被引:34
作者
Auer-Grumbach, Michaela [1 ]
Mauko, Barbara [1 ]
Auer-Grumbach, Piet [1 ]
Pieber, Thomas R. [1 ]
机构
[1] Med Univ Graz, Med Res Ctr, Dept Internal Med, A-8010 Graz, Austria
关键词
hereditary sensory and autonomic; HSN; HSAN; CMT2B; familial dysautonomia; CIPA; NGF;
D O I
10.1385/NMM:8:1:147
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Hereditary sensory neuropathies (HSN), also known as hereditary sensory and autonomic neuropathies (HSAN), are a clinically and genetically heterogeneous group of disorders. They are caused by neuronal atrophy and degeneration, predominantly affecting peripheral sensory and autonomic neurons. Both congenital and juvenile to adulthood onset is possible. Currently, the classification of the HSN depends on the mode of inheritance, age at onset, and clinical presentation. Hallmark features are progressive sensory loss, chronic skin ulcers, and other skin abnormalities. Spontaneous fractures and neuropathic arthropathy are frequent complications and often necessitate amputations. Autonomic features vary between different subgroups. Distal muscle weakness and wasting may be present and is sometimes so prominent that it becomes difficult to distinguish HSN from Charcot-Marie-Tooth syndrome. Recent major advances in molecular genetics have led to the identification of seven gene loci and six-disease causing genes for autosomal-dominant and autosomal-recessive HSN. These genes have been shown to play roles in lipid metabolism and the regulation of intracellular vesicular transport, but also a presumptive transcriptional regulator, a nerve growth factor receptor, and a nerve growth factor have been described among the causative genes in HSN. Nevertheless, it remains unclear how mutations in the known genes lead to the phenotype of HSN. In this review, we summarize the recent progress of the molecular genetics of the HSN and the implicated genes.
引用
收藏
页码:147 / 158
页数:12
相关论文
共 67 条
  • [1] Anand P, 2004, PROG BRAIN RES, V146, P477
  • [2] EGCG corrects aberrant splicing of IKAP mRNA in cells from patients with familial dysautonomia
    Anderson, SL
    Qiu, JS
    Rubin, BY
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 310 (02) : 627 - 633
  • [3] Tocotrienols induce IKBKAP expression:: a possible therapy for familial dysautonomia
    Anderson, SL
    Qiu, JS
    Rubin, BY
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 306 (01) : 303 - 309
  • [4] Familial dysautonomia is caused by mutations of the IKAP gene
    Anderson, SL
    Coli, R
    Daly, IW
    Kichula, EA
    Rork, MJ
    Volpi, SA
    Ekstein, J
    Rubin, BY
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (03) : 753 - 758
  • [5] Phenotype-genotype correlations in a CMT2B family with refined 3q13-q22 locus
    Auer-Grumbach, M
    De Jonghe, P
    Wagner, K
    Verhoeven, K
    Hartung, HP
    Timmerman, V
    [J]. NEUROLOGY, 2000, 55 (10) : 1552 - 1557
  • [6] Autosomal dominant inherited neuropathies with prominent sensory loss and mutilations - A review
    Auer-Grumbach, M
    De Jonghe, P
    Verhoeven, K
    Timmerman, V
    Wagner, K
    Hartung, HP
    Nicholson, GA
    [J]. ARCHIVES OF NEUROLOGY, 2003, 60 (03) : 329 - 334
  • [7] Axelrod FB, 2003, SEMIN NEUROL, V23, P381
  • [8] Familial dysautonomia
    Axelrod, FB
    [J]. MUSCLE & NERVE, 2004, 29 (03) : 352 - 363
  • [9] Survival in familial dysautonomia: Impact of early intervention
    Axelrod, FB
    Goldberg, JD
    Ye, XY
    Maayan, C
    [J]. JOURNAL OF PEDIATRICS, 2002, 141 (04) : 518 - 523
  • [10] SPTLC1 is mutated in hereditary sensory neuropathy, type 1
    Bejaoui, K
    Wu, CY
    Sheffler, MD
    Haan, G
    Ashby, P
    Wu, LC
    de Jong, P
    Brown, RH
    [J]. NATURE GENETICS, 2001, 27 (03) : 261 - 262